Gene therapy Clinical Trials Analysis 2024: FDA Approvals, Pipeline, Therapies, Mechanism of Action, Route of Administration, Companies by DelveInsight | Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech, Replimune

(Albany, USA) DelveInsight's, "Gene Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ Gene Therapy companies and 300+ Gene Therapy drugs in the Gene therapy Competitive landscape. It covers the Gene Therapy therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the Gene Therapy Competitive Landscape Report
• DelveInsight's Gene Therapy report depicts a robust space with 250+ active players working to develop 300+ pipeline therapies for Gene Therapy treatment.
• The leading companies working in the Gene Therapy Market include Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech, Replimune, Istari Oncology, Immvira Pharma, Lokon Pharma, ORCA Therapeutics, Beijing SyngenTech, Tasly Pharmaceuticals, Turnstone Biologics, BioInvent, Transgene, Elicera Therapeutics, Orgenesis, Virttu Biologics, Imugene, Astellas Pharma, Mustang Bio, Virogin Biotech, Memgen, Replimune, Immvira Pharma, PsiOxus Therapeutics, VCN Biosciences, Sorrento Therapeutics, Calidi Biotherapeutics, Replimune, TILT Biotherapeutics, DNAtrix, and others.
• Promising Gene Therapy Therapies in the various stages of development include ABECMA, ADSTILADRIN, ALLOCOR, BREYANZI, CARVYKTI, CLEVECORD, Ducord, HPC Cord Blood, GINTUIT and others.
• December 2023: Sangamo Therapeutics announced a study of Phase 1 & 2 clinical trials for ST-920. This is the first in human treatment with ST-920, a recombinant AAV2/6 vector encoding the cDNA for human a-Gal A. The purpose of this study is to evaluate the safety and tolerability of ascending doses of ST-920. ST-920 aims to provide stable, long-term production of α-Gal A at therapeutic levels in subjects with Fabry disease. The constant production of α-Gal A in humans should, importantly, enable reduction and potentially clearance of Fabry disease substrates Gb3 and lyso-Gb3.
• December 2023: Regenxbio Inc. announced a study of Phase 1 & 2 clinical trials for RGX-202. RGX-202 is a gene therapy designed to deliver a transgene for a novel microdystrophin that includes functional elements of naturally-occurring dystrophin including the C-Terminal (CT) domain. This is a multicenter, open-label dose evaluation clinical study to assess the safety, tolerability and clinical efficacy of a one-time intravenous (IV) dose of RGX-202 in participants with Duchenne.

Request a sample and discover the recent advances in Gene Therapy @ Gene Therapy Competitive Landscape Report- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

The Gene Therapy report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Gene Therapy report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.

Gene Therapy Overview
Gene therapy is a technique that uses a gene(s) to treat, prevent or cure a disease or medical disorder. Often, gene therapy works by adding new copies of a gene that is broken, or by replacing a defective or missing gene in a patient's cells with a healthy version of that gene. Both inherited genetic diseases (e.g., hemophiliaand sickle cell disease) and acquired disorders (e.g., leukemia) have been treated with gene therapy.

Find out more about Gene Therapy Analytical Perspective: In-depth Commercial Assessment @ Gene Therapy Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Gene Therapy Companies and Therapies
• Candel Therapeutics: CAN-2409
• CRISPR Therapeutics: CTX001
• TILT Biotherapeutics: TILT-123
• Akamis Bio: NG-347
• And Many Others.

Gene Therapy Competitive Landscape
The Gene Therapy report comprises of comparative assessment of Companies (by therapy, development stage, and technology).

Gene Therapy Pipeline Report Assessment
• Gene Therapy Company Analysis
• Gene Therapy Therapeutic Assessment
• Gene Therapy Pipeline Assessment
• Gene Therapy Inactive drugs assessment
• Gene Therapy Unmet Needs

Learn more about the emerging Gene Therapy Competitive Landscape @ Gene Therapy Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Gene Therapy Report
• Coverage- Global
• Gene Therapy Therapeutics Assessment: Product Type, Stage and Product Type, Route of Administration, Molecule Type
Gene Therapy Companies- Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech, Replimune, Istari Oncology, Immvira Pharma, Lokon Pharma, ORCA Therapeutics, Beijing SyngenTech, Tasly Pharmaceuticals, Turnstone Biologics, BioInvent, Transgene, Elicera Therapeutics, Orgenesis, Virttu Biologics, Imugene, Astellas Pharma, Mustang Bio, Virogin Biotech, Memgen, Replimune, Immvira Pharma, PsiOxus Therapeutics, VCN Biosciences, Sorrento Therapeutics, Calidi Biotherapeutics, Replimune, TILT Biotherapeutics, DNAtrix, and others.
Gene Therapy Therapies- ABECMA, ADSTILADRIN, ALLOCOR, BREYANZI, CARVYKTI, CLEVECORD, Ducord, HPC Cord Blood, GINTUIT and others.

Dive deep into rich insights for new drugs for Gene Therapy Product Developmental Activities, Visit @ Gene Therapy Research and Development Activities- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Content
Introduction
Executive Summary
Gene Therapy: Overview
Gene Therapy -Analytical Perspective: In-depth Commercial Assessment
Competitive Landscape
Therapeutic Assessment
Gene Therapy: Company and Product Profiles (Marketed Therapies)
Juno Therapeutics, Inc./Bristol-Myers Squibb
BREYANZI
Gene Therapy: Company and Product Profiles (Pipeline Therapies)
Late Stage Products (Phase III)
Candel Therapeutics
CAN-2409
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
Company Name
Product Name
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
TILT Biotherapeutics
TILT-123
Drug profiles in the detailed report…..
Preclinical and Discovery Stage Products
Company Name
Product Name
Drug profiles in the detailed report…..
Inactive Products
Gene Therapy- Unmet needs
Gene Therapy - Market drivers and barriers
Appendix

For further information on the Gene Therapy Report @ Gene Therapy Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Reports:
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Biochips Market: https://www.delveinsight.com/report-store/biochips-market
• Alpha Antitrypsin Market: https://www.delveinsight.com/report-store/alpha-1-antitrypsin-deficiency-a1atd-market
• Pediatric Obesity Market: https://www.delveinsight.com/report-store/pediatric-obesity-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/carcinoid-tumor-market
• Chronic Rhinosinustis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Chronic Rhinosinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/rheumatoid-arthritis-ra-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Hemophilia B Market: https://www.delveinsight.com/report-store/hemophilia-b-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market
• Acute Coronary Syndrome Market: https://www.delveinsight.com/report-store/acute-coronary-syndrome-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Pain Management Devices Market: https://www.delveinsight.com/report-store/pain-management-devices-market
• Acute Pulmonary Embolism Market: https://www.delveinsight.com/report-store/acute-pulmonary-embolism-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market

Contact Us:
Ankit Nigam
Marketing Manager
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.